Cargando…

Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy

Becker muscular dystrophy (BMD) is an X-linked neuromuscular disease characterized by progressive muscle weakness that currently has no cure. Immune-mediated necrotizing myopathy (IMNM) is a type of autoimmune inflammatory myopathy characterized by proximal muscle weakness that is treated with immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Munekane, Asami, Ohsawa, Yutaka, Okubo, Mariko, Nagai, Taiji, Nishimura, Hirotake, Nishino, Ichizo, Sunada, Yoshihide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208778/
https://www.ncbi.nlm.nih.gov/pubmed/36130887
http://dx.doi.org/10.2169/internalmedicine.0202-22
_version_ 1785046742045032448
author Munekane, Asami
Ohsawa, Yutaka
Okubo, Mariko
Nagai, Taiji
Nishimura, Hirotake
Nishino, Ichizo
Sunada, Yoshihide
author_facet Munekane, Asami
Ohsawa, Yutaka
Okubo, Mariko
Nagai, Taiji
Nishimura, Hirotake
Nishino, Ichizo
Sunada, Yoshihide
author_sort Munekane, Asami
collection PubMed
description Becker muscular dystrophy (BMD) is an X-linked neuromuscular disease characterized by progressive muscle weakness that currently has no cure. Immune-mediated necrotizing myopathy (IMNM) is a type of autoimmune inflammatory myopathy characterized by proximal muscle weakness that is treated with immunosuppressive therapy. We herein report a patient diagnosed with BMD complicated with IMNM by a pathological analysis. Notably, the patient had an elevated serum anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody level. Oral glucocorticoid and methotrexate treatment partially improved the muscle weakness with decreased levels of serum creatine kinase. An accurate diagnosis is important for therapeutic decisions in these complicated cases.
format Online
Article
Text
id pubmed-10208778
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-102087782023-05-25 Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy Munekane, Asami Ohsawa, Yutaka Okubo, Mariko Nagai, Taiji Nishimura, Hirotake Nishino, Ichizo Sunada, Yoshihide Intern Med Case Report Becker muscular dystrophy (BMD) is an X-linked neuromuscular disease characterized by progressive muscle weakness that currently has no cure. Immune-mediated necrotizing myopathy (IMNM) is a type of autoimmune inflammatory myopathy characterized by proximal muscle weakness that is treated with immunosuppressive therapy. We herein report a patient diagnosed with BMD complicated with IMNM by a pathological analysis. Notably, the patient had an elevated serum anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody level. Oral glucocorticoid and methotrexate treatment partially improved the muscle weakness with decreased levels of serum creatine kinase. An accurate diagnosis is important for therapeutic decisions in these complicated cases. The Japanese Society of Internal Medicine 2022-09-21 2023-05-01 /pmc/articles/PMC10208778/ /pubmed/36130887 http://dx.doi.org/10.2169/internalmedicine.0202-22 Text en Copyright © 2023 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Munekane, Asami
Ohsawa, Yutaka
Okubo, Mariko
Nagai, Taiji
Nishimura, Hirotake
Nishino, Ichizo
Sunada, Yoshihide
Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy
title Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy
title_full Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy
title_fullStr Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy
title_full_unstemmed Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy
title_short Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy
title_sort becker muscular dystrophy accompanied by anti-hmgcr antibody-positive immune-mediated necrotizing myopathy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208778/
https://www.ncbi.nlm.nih.gov/pubmed/36130887
http://dx.doi.org/10.2169/internalmedicine.0202-22
work_keys_str_mv AT munekaneasami beckermusculardystrophyaccompaniedbyantihmgcrantibodypositiveimmunemediatednecrotizingmyopathy
AT ohsawayutaka beckermusculardystrophyaccompaniedbyantihmgcrantibodypositiveimmunemediatednecrotizingmyopathy
AT okubomariko beckermusculardystrophyaccompaniedbyantihmgcrantibodypositiveimmunemediatednecrotizingmyopathy
AT nagaitaiji beckermusculardystrophyaccompaniedbyantihmgcrantibodypositiveimmunemediatednecrotizingmyopathy
AT nishimurahirotake beckermusculardystrophyaccompaniedbyantihmgcrantibodypositiveimmunemediatednecrotizingmyopathy
AT nishinoichizo beckermusculardystrophyaccompaniedbyantihmgcrantibodypositiveimmunemediatednecrotizingmyopathy
AT sunadayoshihide beckermusculardystrophyaccompaniedbyantihmgcrantibodypositiveimmunemediatednecrotizingmyopathy